Trials / Not Yet Recruiting
Not Yet RecruitingNCT07088328
Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial
Effect of Pentoxyphylline in Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 1 Hour – 5 Days
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine the value of Pentoxifylline for nephroprotection in these neonates with perinatal asphyxia, using cystatin C, regional oxygenation measured near infrared spectroscopy and renal Doppler sonography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pentoxifylline | Intravenous administration for 3 days |
| OTHER | placebo distilled water | Intravenous administration for 3 days |
Timeline
- Start date
- 2025-07-30
- Primary completion
- 2026-01-30
- Completion
- 2026-03-02
- First posted
- 2025-07-28
- Last updated
- 2025-07-28
Source: ClinicalTrials.gov record NCT07088328. Inclusion in this directory is not an endorsement.